(Q42556246)

2 November 2017

0 references

Probucol-associated tachyarrhythmic events and QT prolongation: importance of gender (English)

1 reference

2 November 2017

Reinoehl J

1

1 reference

2 November 2017

Frankovich D

2

1 reference

2 November 2017

Machado C

3

1 reference

2 November 2017

Kawasaki R

4

1 reference

2 November 2017

Baga JJ

5

1 reference

2 November 2017

Pires LA

6

1 reference

2 November 2017

Steinman RT

7

1 reference

2 November 2017

Fromm BS

8

1 reference

2 November 2017

Lehmann MH

9

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 June 1996

1 reference

2 November 2017

published in

American Heart Journal

1 reference

2 November 2017

volume

131

1 reference

2 November 2017

issue

6

1 reference

2 November 2017

page(s)

1184-1191

1 reference

Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

The probucol experience: a review of the past and a look at the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

Probucol inhibits oxidative modification of low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

QT-interval prolongation produced by probucol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

Propranolol for probucol-induced QT prolongation with polymorphic ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

Polymorphic ventricular tachycardia (Torsade de Pointes) associated with the use of probucol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

The effects of probucol on QT/QS2 relation and systolic time intervals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

Prolongation of the QT interval induced by probucol: demonstration of a method for determining QT interval change induced by a drug.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

Electrocardiographic effects of probucol. A controlled prospective clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

Probucol and the QT interval

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

Possible female preponderance in prenylamine-induced 'torsade de pointes' tachycardia. Short communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

Acquired long QT syndrome due to antiarrhythmic drugs and bradyarrhythmias

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

inferred from DOI database lookup

7 January 2021

based on heuristic

A new look at torsades de pointes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

Safety of bepridil: from review of the European data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

Proarrhythmic effects of antiarrhythmic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

Torsade de pointes associated with the use of intravenous haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

Probucol-induced QT prolongation and torsades de pointes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990095-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-8703(96)90095-2

1 reference

2 November 2017

1 reference